The DOI matches its Crossref record; 169 of the 169 references it cites were found in a registry or an index.
Anti-Inflammatory Effects of Statins: Clinical Evidence and Basic Mechanisms
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Furchgott, R. F., & Zawadzki, J. V. (1980) · Nature · doi:10.1038/288373a0 · Cited by 12,064
Inflammation, Atherosclerosis, and Coronary Artery Disease
Hansson, G. K. (2005) · New England Journal of Medicine · doi:10.1056/nejmra043430 · Cited by 8,773
OLSSON, A. G., McMurray, J. J. V., Thorgeirsson, G., Spaulding, C. M., Slattery, J., Pyörälà, K., Færgeman, O., Wright, R. S., Berg, K. M., Wilhelmsen, L., et al. (1994) · The Lancet · Cited by 8,467
Inflammation in atherosclerosis
Libby, P. (2002) · Nature · doi:10.1038/nature01323 · Cited by 8,315
Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
Shepherd, J., Cobbe, S. M., Ford, I., Isles, C. G., Lorimer, A. R., Macfarlane, P. W., McKillop, J. H., & Packard, C. J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511163332001 · Cited by 7,449
Sacks, F. M., Pfeffer, M. A., Moye, L. A., Rouleau, J. L., Rutherford, J. D., Cole, T. G., Brown, L., Warnica, J. W., Arnold, J. M. O., Wun, C.-C., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610033351401 · Cited by 7,439
Ridker, P. M., Hennekens, C. H., Buring, J. E., & Rifai, N. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003233421202 · Cited by 5,850
Self-citationInflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
Ridker, P. M., Cushman, M., Stampfer, M. J., Tracy, R. P., & Hennekens, C. H. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704033361401 · Cited by 5,504
Self-citationRegulation of the mevalonate pathway
Goldstein, J. L., & Brown, M. S. (1990) · Nature · doi:10.1038/343425a0 · Cited by 5,394
(1998) · New England Journal of Medicine · doi:10.1056/nejm199811053391902 · Cited by 5,261
Downs, J. R., Clearfield, M., Weis, S., Whitney, E., Shapiro, D. R., Beere, P. A., Langendorfer, A., Stein, E. A., Kruyer, W., Gotto, Jr., et al. (1998) · JAMA · doi:10.1001/jama.279.20.1615 · Cited by 5,236
Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide.
Ignarro, L. J., Buga, G. M., Wood, K. S., Byrns, R. E., & Chaudhuri, G. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.24.9265 · Cited by 5,074
Hayden, M. S., & Ghosh, S. (2004) · Genes & Development · doi:10.1101/gad.1228704 · Cited by 3,842
Sever, P. S., Dahlöf, B., Poulter, N. R., Wedel, H., Beevers, G., Caulfield, M., Collins, R., Kjeldsen, S. E., Kristinsson, A., McInnes, G. T., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12948-0 · Cited by 3,782
SCANDINAVIANSIMVASTATINSURVIVAL (1994) · The Lancet · doi:10.1016/s0140-6736(94)90566-5 · Cited by 3,645
The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation
Ricote, M., Li, A. C., Willson, T. M., Kelly, C. J., & Glass, C. K. (1998) · Nature · doi:10.1038/34178 · Cited by 3,525
Molecular Regulation of Vascular Smooth Muscle Cell Differentiation in Development and Disease
Owens, G. K., Kumar, M. S., & Wamhoff, B. R. (2004) · Physiological Reviews · doi:10.1152/physrev.00041.2003 · Cited by 3,471
PREVENTION OF CORONARY HEART DISEASE WITH PRAVASTATIN IN MEN WITH HYPERCHOLESTEROLEMIA
Hepherd, J. A. S., Obbe, S. T. M. C., Ord, I. A. F., Sles, C. H. G. I., Orimer, A. R. O. L., Acfarlane, P. E. W. M., Illop, J. A. H. M. C. K., Ackard, C. H. J. P., & Roup, S. T. G. (1995) · Cited by 3,453
Galis, Z. S., Sukhova, G. K., Lark, M. W., & Libby, P. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117619 · Cited by 2,539
Schwartz, G. G. (2001) · JAMA · doi:10.1001/jama.285.13.1711 · Cited by 2,499
Ridker, P. M., Rifai, N., Stampfer, M. J., & Hennekens, C. H. (2000) · Circulation · doi:10.1161/01.cir.101.15.1767 · Cited by 2,429
Self-citationRho GTPases and signaling networks
Van Aelst, L., & D’Souza-Schorey, C. (1997) · Genes & Development · doi:10.1101/gad.11.18.2295 · Cited by 2,358
C-Reactive Protein Levels and Outcomes after Statin Therapy
Ridker, P. M., Cannon, C. P., Morrow, D., Rifai, N., Rose, L. M., McCabe, C. H., Pfeffer, M. A., & Braunwald, E. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042378 · Cited by 2,292
Self-citationGarg, U. C., & Hassid, A. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114081 · Cited by 2,155
Serum Cholesterol, Lipoproteins, and the Risk of Coronary Heart Disease: The Framingham Study
KANNEL, W. B., CASTELLI, W. P., GORDON, T., & MCNAMARA, P. M. (1971) · Annals of Internal Medicine · doi:10.7326/0003-4819-74-1-1 · Cited by 2,057
PLEIOTROPIC EFFECTS OF STATINS
Liao, J. K., & Laufs, U. (2005) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.45.120403.095748 · Cited by 1,994
Boring, L., Gosling, J., Cleary, M., & Charo, I. F. (1998) · Nature · doi:10.1038/29788 · Cited by 1,965
Upregulation of Endothelial Nitric Oxide Synthase by HMG CoA Reductase Inhibitors
Laufs, U., La Fata, V., Plutzky, J., & Liao, J. K. (1998) · Circulation · doi:10.1161/01.cir.97.12.1129 · Cited by 1,839
AP-1 in cell proliferation and survival
Shaulian, E., & Karin, M. (2001) · Oncogene · doi:10.1038/sj.onc.1204383 · Cited by 1,736
Endothelial Expression of a Mononuclear Leukocyte Adhesion Molecule During Atherogenesis
Cybulsky, M. I., & Gimbrone, M. A. (1991) · Science · doi:10.1126/science.1990440 · Cited by 1,712
Tuomilehto, J., Vidgren, G., Toivanen, L., Tuomilehto-Wolf, E., Kohtamaki, K., Stengård, J., Zimmet, P., Mackay, I. R., Rowley, M., & Koskela, P. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92521-6 · Cited by 1,692
Structural mechanism for statin inhibition of HMG-CoA reductase
Istvan, E. S., & Deisenhofer, J. (2001) · Science · doi:10.1126/science.1059344 · Cited by 1,644
Albert, M. A., Danielson, E., Rifai, N., Ridker, P. M., & for the PRINCE Investigators (2001) · JAMA · doi:10.1001/jama.286.1.64 · Cited by 1,641
Self-citationGu, L., Okada, Y., Clinton, S. K., Gerard, C., Sukhova, G. K., Libby, P., & Rollins, B. J. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80139-2 · Cited by 1,575
Ridker, P. M., Rifai, N., Clearfield, M., Downs, J. R., Weis, S. E., Miles, J. S., & Gotto, A. M. (2001) · New England Journal of Medicine · doi:10.1056/nejm200106283442601 · Cited by 1,557
Self-citationLong-Term Effects of Pravastatin on Plasma Concentration of C-reactive Protein
Ridker, P. M., Rifai, N., Pfeffer, M. A., Sacks, F., & Braunwald, E. (1999) · Circulation · doi:10.1161/01.cir.100.3.230 · Cited by 1,478
Self-citationENDOGENOUS NITRIC OXIDE INHIBITS HUMAN PLATELET ADHESION TO VASCULAR ENDOTHELIUM
Radomski, M. W., Palmer, R. M. J., & Moncada, S. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91481-4 · Cited by 1,437
Ridker, P. M., Rifai, N., Pfeffer, M. A., Sacks, F. M., Moye, L. A., Goldman, S., Flaker, G. C., & Braunwald, E. (1998) · Circulation · doi:10.1161/01.cir.98.9.839 · Cited by 1,389
Self-citationStatins as a newly recognized type of immunomodulator.
Kwak, B., Mulhaupt, F., Myit, S., & Mach, F. (2000) · Nature Medicine · doi:10.1038/82219 · Cited by 1,383
Statin Therapy, LDL Cholesterol, C-Reactive Protein, and Coronary Artery Disease
Nissen, S. E., Tuzcu, E. M., Schoenhagen, P., Crowe, T., Sasiela, W. J., Tsai, J., Orazem, J., Magorien, R. D., O'Shaughnessy, C., & Ganz, P. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042000 · Cited by 1,325
Effect of pravastatin on outcomes after cardiac transplantation
Kobashigawa, J. A., Katznelson, S., Laks, H., Johnson, J. A., Yeatman, L., Wang, X. M., Chia, D., Terasaki, P. I., Sabad, A., Cogert, G. A., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199509073331003 · Cited by 1,301
Ridker, P. M., Hennekens, C. H., Roitman-Johnson, B., Stampfer, M. J., & Allen, J. (1998) · The Lancet · doi:10.1016/s0140-6736(97)09032-6 · Cited by 1,229
Lindahl, B., Toss, H., Siegbahn, A., Venge, P., & Wallentin, L. (2000) · New England Journal of Medicine · doi:10.1056/nejm200010193431602 · Cited by 1,224
Platelet Activation in Unstable Coronary Disease
Fitzgerald, D. J., Roy, L., Catella, F., & FitzGerald, G. A. (1986) · New England Journal of Medicine · doi:10.1056/nejm198610163151602 · Cited by 1,141
Anderson, T. J., Meredith, I. T., Yeung, A. C., Frei, B., Selwyn, A. P., & Ganz, P. (1995) · New England Journal of Medicine · doi:10.1056/nejm199502233320802 · Cited by 1,109
Treasure, C. B., Klein, J. L., Weintraub, W. S., Talley, J. D., Stillabower, M. E., Kosinski, A. S., Zhang, J., Boccuzzi, S. J., Cedarholm, J. C., & Alexander, R. W. (1995) · New England Journal of Medicine · doi:10.1056/nejm199502233320801 · Cited by 1,097
&NA; (1996) · Journal of Occupational & Environmental Medicine · doi:10.1097/00043764-199605000-00005 · Cited by 1,070
Weitz-Schmidt, G., Welzenbach, K., Brinkmann, V., Kamata, T., Kallen, J., Bruns, C., Cottens, S., Takada, Y., & Hommel, U. (2001) · Nature Medicine · doi:10.1038/89058 · Cited by 1,041
Crisby, M., Nordin-Fredriksson, G., Shah, P. K., Yano, J., Zhu, J., & Nilsson, J. (2001) · Circulation · doi:10.1161/01.cir.103.7.926 · Cited by 1,001
ML-236A, ML-236B, and ML-236C, new inhibitors of cholesterogensis produced by Penicillium citrinum.
ENDO, A., KURODA, M., & TSUJITA, Y. (1976) · The Journal of Antibiotics · doi:10.7164/antibiotics.29.1346 · Cited by 954
Simvastatin, an HMG–Coenzyme A Reductase Inhibitor, Improves Endothelial Function Within 1 Month
O'Driscoll, G., Green, D., & Taylor, R. R. (1997) · Circulation · doi:10.1161/01.cir.95.5.1126 · Cited by 952
Stability and Instability: Two Faces of Coronary Atherosclerosis: The Paul Dudley White Lecture 1995
Davies, M. J. (1996) · Circulation · doi:10.1161/01.cir.94.8.2013 · Cited by 915
Ylä-Herttuala, S., Lipton, B. A., Rosenfeld, M. E., Särkioja, T., Yoshimura, T., Leonard, E. J., Witztum, J. L., & Steinberg, D. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.12.5252 · Cited by 872
Identification of an endothelial cell cofactor for thrombin-catalyzed activation of protein C.
Esmon, C. T., & Owen, W. G. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.4.2249 · Cited by 830
Statins and the Risk of Colorectal Cancer
Poynter, J. N., Gruber, S. B., Higgins, P. D. R., Almog, R., Bonner, J. D., Rennert, H. S., Low, M., Greenson, J. K., & Rennert, G. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043792 · Cited by 816
Ridker, P. M., Rifai, N., & Clearfield, M. (2001) · ACC Current Journal Review · doi:10.1016/s1062-1458(01)00460-3 · Cited by 760
Self-citationRidker, P. M., Rifai, N., Cook, N. R., Bradwin, G., & Buring, J. E. (2005) · JAMA · doi:10.1001/jama.294.3.326 · Cited by 744
Self-citationHebert, P. R. (1997) · JAMA · doi:10.1001/jama.1997.03550040069040 · Cited by 740
NF-κB: pivotal mediator or innocent bystander in atherogenesis?
Collins, T., & Cybulsky, M. I. (2001) · Journal of Clinical Investigation · doi:10.1172/jci10373 · Cited by 727 · cited 1×
“For example, diverse pro-inflammatory stimuli converge on a few key transcriptional pathways such as nuclear factor-κB (NF-κB) and activator protein-1 (AP1) that induce the expression of pro-adhesive and pro-thrombotic genes in vascular cell”
BackgroundKLF2 Is a Novel Transcriptional Regulator of Endothelial Proinflammatory Activation
SenBanerjee, S., Lin, Z., Atkins, G. B., Greif, D. M., Rao, R. M., Kumar, A., Feinberg, M. W., Chen, Z., Simon, D. I., Luscinskas, F. W., et al. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031132 · Cited by 723
Self-citationDekker, R. J., van Soest, S., Fontijn, R. D., Salamanca, S., de Groot, P. G., VanBavel, E., Pannekoek, H., & Horrevoets, A. J. G. (2002) · Blood · doi:10.1182/blood-2002-01-0046 · Cited by 692
Ballantyne, C. M., Houri, J., Notarbartolo, A., Melani, L., Lipka, L. J., Suresh, R., Sun, S., LeBeaut, A. P., Sager, P. T., & Veltri, E. P. (2003) · Circulation · doi:10.1161/01.cir.0000068312.21969.c8 · Cited by 687
Sukhova, G. K., Schönbeck, U., Rabkin, E., Schoen, F. J., Poole, A. R., Billinghurst, R. C., & Libby, P. (1999) · Circulation · doi:10.1161/01.cir.99.19.2503 · Cited by 657
Ridker, P. M., Wilson, P. W. F., & Grundy, S. M. (2004) · Circulation · doi:10.1161/01.cir.0000132467.45278.59 · Cited by 645
Self-citationRho kinase, a promising drug target for neurological disorders
Mueller, B. K., Mack, H., & Teusch, N. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1719 · Cited by 608
Görlach, A., Brandes, R. P., Nguyen, K., Amidi, M., Dehghani, F., & Busse, R. (2000) · Circulation Research · doi:10.1161/01.res.87.1.26 · Cited by 598 · cited 1×
“By inhibiting Rac isoprenylation, statins can lead to a reduction in NADPH oxidase assembly and, consequently, generation of RO”
BackgroundCellular Antioxidant Effects of Atorvastatin In Vitro and In Vivo
Wassmann, S., Laufs, U., Müller, K., Konkol, C., Ahlbory, K., Bäumer, A. T., Linz, W., Böhm, M., & Nickenig, G. (2002) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/hq0202.104081 · Cited by 592
Aikawa, M., Rabkin, E., Sugiyama, S., Voglic, S. J., Fukumoto, Y., Furukawa, Y., Shiomi, M., Schoen, F. J., & Libby, P. (2001) · Circulation · doi:10.1161/01.cir.103.2.276 · Cited by 588
The evolving role of statins in the management of atherosclerosis
Vaughan, C. J., Gotto, A. M., & Basson, C. T. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00525-2 · Cited by 574
Li, A. C., Binder, C. J., Gutierrez, A., Brown, K. K., Plotkin, C. R., Pattison, J. W., Valledor, A. F., Davis, R. A., Willson, T. M., Witztum, J. L., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci18730 · Cited by 573
Lee, R. T., & Libby, P. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.10.1859 · Cited by 558
Single LDL Apheresis Improves Endothelium-Dependent Vasodilatation in Hypercholesterolemic Humans
Tamai, O., Matsuoka, H., Itabe, H., Wada, Y., Kohno, K., & Imaizumi, T. (1997) · Circulation · doi:10.1161/01.cir.95.1.76 · Cited by 542
Activation of the nuclear factor-kappaB by Rho, CDC42, and Rac-1 proteins
Perona, R., Montaner, S., Saniger, L., Sánchez-Pérez, I., Bravo, R., & Lacal, J. C. (1997) · Genes & Development · doi:10.1101/gad.11.4.463 · Cited by 519
Dupuis, J., Tardif, J.-C., Cernacek, P., & Théroux, P. (1999) · Circulation · doi:10.1161/01.cir.99.25.3227 · Cited by 513
HEBERT, P. R., GAZIANO, J. M., CHAN, K. S., & HENNEKENS, C. H. (1998) · Survey of Anesthesiology · doi:10.1097/00132586-199806000-00060 · Cited by 506
Inflammation, Immunity, and HMG-CoA Reductase Inhibitors: Statins as Antiinflammatory Agents?
Schönbeck, U., & Libby, P. (2004) · Circulation · doi:10.1161/01.cir.0000129505.34151.23 · Cited by 498
Rho-Kinase Is an Important Therapeutic Target in Cardiovascular Medicine
Shimokawa, H., & Takeshita, A. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000176193.83629.c8 · Cited by 480
Soluble CD40L and Cardiovascular Risk in Women
Schönbeck, U., Varo, N., Libby, P., Buring, J., & Ridker, P. M. (2001) · Circulation · doi:10.1161/hc4401.099447 · Cited by 459
Self-citationPagano, P. J., Clark, J. K., Cifuentes-Pagano, M. E., Clark, S. M., Callis, G. M., & Quinn, M. T. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.26.14483 · Cited by 455
Pharmacogenetic Study of Statin Therapy and Cholesterol Reduction
Chasman, D. I. (2004) · JAMA · doi:10.1001/jama.291.23.2821 · Cited by 453
Nitric Oxide Regulates Exocytosis by S-Nitrosylation of N-ethylmaleimide-Sensitive Factor
Matsushita, K., Morrell, C. N., Cambien, B., Yang, S.-X., Yamakuchi, M., Bao, C., Hara, M. R., Quick, R. A., Cao, W., O'Rourke, B., et al. (2003) · Cell · doi:10.1016/s0092-8674(03)00803-1 · Cited by 448
Wenke, K., Meiser, B., Thiery, J., Nagel, D., von Scheidt, W., Steinbeck, G., Seidel, D., & Reichart, B. (1997) · Circulation · doi:10.1161/01.cir.96.5.1398 · Cited by 444
Esmon, C. T. (2003) · Journal of Thrombosis and Haemostasis · doi:10.1046/j.1538-7836.2003.00261.x · Cited by 442
Landmesser, U., Bahlmann, F., Mueller, M., Spiekermann, S., Kirchhoff, N., Schulz, S., Manes, C., Fischer, D., de Groot, K., Fliser, D., et al. (2005) · Circulation · doi:10.1161/01.cir.0000164260.82417.3f · Cited by 425
Bustos, C., Hernández-Presa, M. A., Ortego, M., Tuñón, J., Ortega, L., Pérez, F., Díaz, C., Hernández, G., & Egido, J. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00487-2 · Cited by 422
Ridker, P. M. (2003) · Circulation · doi:10.1161/01.cir.0000100688.17280.e6 · Cited by 421
Self-citationLKLF: A Transcriptional Regulator of Single-Positive T Cell Quiescence and Survival
Kuo, C. T., Veselits, M. L., & Leiden, J. M. (1997) · Science · doi:10.1126/science.277.5334.1986 · Cited by 419
Statin-induced inhibition of the Rho-signaling pathway activates PPARα and induces HDL apoA-I
Martin, G., Duez, H., Blanquart, C., Berezowski, V., Poulain, P., Fruchart, J.-C., Najib-Fruchart, J., Glineur, C., & Staels, B. (2001) · Journal of Clinical Investigation · doi:10.1172/jci10852 · Cited by 417
Ridker, P. M., Rifai, N., & Lowenthal, S. P. (2001) · Circulation · doi:10.1161/01.cir.103.9.1191 · Cited by 415
Self-citationWeber, C., Erl, W., Weber, K. S. C., & Weber, P. C. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00324-0 · Cited by 411
Guijarro, C., Blanco-Colio, L. M., Ortego, M., Alonso, C., Ortiz, A., Plaza, J. J., Díaz, C., Hernández, G., & Egido, J. (1998) · Circulation Research · doi:10.1161/01.res.83.5.490 · Cited by 390
Malik, I., Danesh, J., Whincup, P., Bhatia, V., Papacosta, O., Walker, M., Lennon, L., Thomson, A., & Haskard, D. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06104-9 · Cited by 388
Premature mortality from coronary heart disease. The Framingham study
Gordon, T. (1971) · JAMA · doi:10.1001/jama.215.10.1617 · Cited by 387
Kruppel-Like Factor 2 (KLF2) Regulates Endothelial Thrombotic Function
Lin, Z., Kumar, A., SenBanerjee, S., Staniszewski, K., Parmar, K., Vaughan, D. E., Gimbrone, M. A., Balasubramanian, V., García-Cardeña, G., & Jain, M. K. (2005) · Circulation Research · doi:10.1161/01.res.0000159707.05637.a1 · Cited by 385
Self-citationSoluble CD40L: Risk Prediction After Acute Coronary Syndromes
Varo, N., de Lemos, J. A., Libby, P., Morrow, D. A., Murphy, S. A., Nuzzo, R., Gibson, C. M., Cannon, C. P., Braunwald, E., & Schönbeck, U. (2003) · Circulation · doi:10.1161/01.cir.0000088521.04017.13 · Cited by 384
Fukumoto, Y., Libby, P., Rabkin, E., Hill, C. C., Enomoto, M., Hirouchi, Y., Shiomi, M., & Aikawa, M. (2001) · Circulation · doi:10.1161/01.cir.103.7.993 · Cited by 384
Laufs, U., Marra, D., Node, K., & Liao, J. K. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.31.21926 · Cited by 380
C-Reactive Protein Accelerates the Progression of Atherosclerosis in Apolipoprotein E–Deficient Mice
Paul, A., Ko, K. W. S., Li, L., Yechoor, V., McCrory, M. A., Szalai, A. J., & Chan, L. (2004) · Circulation · doi:10.1161/01.cir.0000114526.50618.24 · Cited by 373
Kuo, C. T., Veselits, M. L., Barton, K. P., Lu, M. M., Clendenin, C., & Leiden, J. M. (1997) · Genes & Development · doi:10.1101/gad.11.22.2996 · Cited by 369
Kruppel-Like Factor 2 as a Novel Mediator of Statin Effects in Endothelial Cells
Sen-Banerjee, S., Mir, S., Lin, Z., Hamik, A., Atkins, G. B., Das, H., Banerjee, P., Kumar, A., & Jain, M. K. (2005) · Circulation · doi:10.1161/circulationaha.104.525774 · Cited by 354
Self-citationWilliams, J. K., Sukhova, G. K., Herrington, D. M., & Libby, P. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00537-8 · Cited by 348
Colli, S., Eligini, S., Lalli, M., Camera, M., Paoletti, R., & Tremoli, E. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.2.265 · Cited by 348
Dichtl, W., Dulak, J., Frick, M., Alber, H. F., Schwarzacher, S. P., Ares, M. P. S., Nilsson, J., Pachinger, O., & Weidinger, F. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000043456.48735.20 · Cited by 344
S‐nitroso‐glutathione inhibits platelet activation in vitro and in vivo
Radomski, M. W., Rees, D. D., Dutra, A., & Moncada, S. (1992) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1992.tb14517.x · Cited by 326
Blauw, G. J., Lagaay, A. M., Smelt, A. H. M., & Westendorp, R. G. J. (1997) · Stroke · doi:10.1161/01.str.28.5.946 · Cited by 311
Inhibition of Monocyte Chemotactic Protein-1 Synthesis by Statins
Romano, M., Diomede, L., Sironi, M., Massimiliano, L., Sottocorno, M., Polentarutti, N., Guglielmotti, A., Albani, D., Bruno, A., Fruscella, P., et al. (2000) · Laboratory Investigation · doi:10.1038/labinvest.3780115 · Cited by 298
Increased Thrombosis After Arterial Injury in Human C-Reactive Protein–Transgenic Mice
Danenberg, H. D., Szalai, A. J., Swaminathan, R. V., Peng, L., Chen, Z., Seifert, P., Fay, W. P., Simon, D. I., & Edelman, E. R. (2003) · Circulation · doi:10.1161/01.cir.0000085568.13915.1e · Cited by 285
Anderson, K. P., Kern, C. B., Crable, S. C., & Lingrel, J. B. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.11.5957 · Cited by 262
Vascular Endothelium, Hemodynamic Forces, and Atherogenesis
Gimbrone, M. A. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65090-0 · Cited by 260
Tsunekawa, T., Hayashi, T., Kano, H., Sumi, D., Matsui-Hirai, H., Thakur, N. K., Egashira, K., & Iguchi, A. (2001) · Circulation · doi:10.1161/hc2901.094094 · Cited by 257
Statins Exert Endothelial Atheroprotective Effects via the KLF2 Transcription Factor
Parmar, K. M., Nambudiri, V., Dai, G., Larman, H. B., Gimbrone, M. A., & García-Cardeña, G. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.c500144200 · Cited by 253
Arnaud, C., Burger, F., Steffens, S., Veillard, N. R., Nguyen, T. H., Trono, D., & Mach, F. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000163840.63685.0c · Cited by 247
Rikitake, Y. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(00)00468-8 · Cited by 246
In Vivo Anti-Inflammatory Effect of Statins Is Mediated by Nonsterol Mevalonate Products
Diomede, L., Albani, D., Sottocorno, M., Donati, M. B., Bianchi, M., Fruscella, P., & Salmona, M. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/hq0801.094222 · Cited by 246
Pathology of the unstable plaque
Virmani, R., Burke, A. P., Farb, A., & Kolodgie, F. D. (2002) · Progress in Cardiovascular Diseases · doi:10.1053/pcad.2002.122475 · Cited by 244
Gauthier, T. W., Scalia, R., Murohara, T., Guo, J.-P., & Lefer, A. M. (1995) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.15.10.1652 · Cited by 242
Transcription factor LKLF is sufficient to program T cell quiescence via a c-Myc–dependent pathway
Buckley, A. F., Kuo, C. T., & Leiden, J. M. (2001) · Nature Immunology · doi:10.1038/90633 · Cited by 239
Ridker, P. M., Morrow, D. A., Rose, L. M., Rifai, N., Cannon, C. P., & Braunwald, E. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.02.080 · Cited by 236
Self-citationSimon, D. I., Chen, Z., Seifert, P., Edelman, E. R., Ballantyne, C. M., & Rogers, C. (2000) · Journal of Clinical Investigation · doi:10.1172/jci7811 · Cited by 228
Preprocedural C-reactive protein levels and cardiovascular events after coronary stent implantation
Walter, D. H., Fichtlscherer, S., Sellwig, M., Auch-Schwelk, W., Schächinger, V., & Zeiher, A. M. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)01193-1 · Cited by 222
THE EFFECT OF PRAVASTATIN ON ACUTE REJECTION AFTER KIDNEY TRANSPLANTATION-A PILOT STUDY1
Katznelson, S., Wilkinson, A. H., Kobashigawa, J. A., Wang, X.-M., Chia, D., Ozawa, M., Zhong, H.-P., Hirata, M., Cohen, A. H., Terasaki, P. I., et al. (1996) · Transplantation · doi:10.1097/00007890-199605270-00010 · Cited by 209
Antioxidants and Atherosclerosis: Don’t Throw Out the Baby With the Bath Water
Jialal, I., & Devaraj, S. (2003) · Circulation · doi:10.1161/01.cir.0000048966.26216.4c · Cited by 208
Shimokawa, H., Hiramori, K., Iinuma, H., Hosoda, S., Kishida, H., Osada, H., Katagiri, T., Yamauchi, K., Yui, Y., Minamino, T., et al. (2002) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200211000-00013 · Cited by 193
Transgenic human C-reactive protein is not proatherogenic in apolipoprotein E-deficient mice
Hirschfield, G. M., Gallimore, J. R., Kahan, M. C., Hutchinson, W. L., Sabin, C. A., Benson, G. M., Dhillon, A. P., Tennent, G. A., & Pepys, M. B. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503202102 · Cited by 192
Yoshida, M., Sawada, T., Ishii, H., Gerszten, R. E., Rosenzweig, A., Gimbrone, M. A., Yasukochi, Y., & Numano, F. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/hq0701.092143 · Cited by 187
Wang, J. M., Sica, A., Peri, G., Walter, S., Padura, I. M., Libby, P., Ceska, M., Lindley, I., Colotta, F., & Mantovani, A. (1991) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.11.5.1166 · Cited by 186
Morikawa, S., Takabe, W., Mataki, C., Kanke, T., Itoh, T., Wada, Y., Izumi, A., Saito, Y., Hamakubo, T., & Kodama, T. (2002) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.9.178 · Cited by 167
Wilson, S. H., Simari, R. D., Best, P. J. M., Peterson, T. E., Lerman, L. O., Aviram, M., Nath, K. A., Holmes, D. R., & Lerman, A. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.21.1.122 · Cited by 166
Kumar, A., Lin, Z., SenBanerjee, S., & Jain, M. K. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.14.5893-5903.2005 · Cited by 165
Self-citationCholesterol reduction rapidly improves endothelial function after acute coronary syndromes
Dupuis, J., Tardif, J.-C., & Théroux, P. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)80661-x · Cited by 158
Zelvyté, I., Dominaitiene, R., Crisby, M., & Janciauskiene, S. M. (2002) · Pharmacological Research · doi:10.1006/phrs.2001.0922 · Cited by 152
Regulation of platelet granule exocytosis by S-nitrosylation
Morrell, C. N., Matsushita, K., Chiles, K. A., Scharpf, R. B., Yamakuchi, M., Mason, R. J. A., Bergmeier, W., Mankowski, J. L., Baldwin, W. M., Faraday, N. R., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408310102 · Cited by 141
Statins for Atherosclerosis — As Good as It Gets?
Ehrenstein, M. R., Jury, E. C., & Mauri, C. (2005) · New England Journal of Medicine · doi:10.1056/nejme048326 · Cited by 138
Rasmussen, L. M., Hansen, P. R., NABIPOUR, M. T., Olesen, P., Kristiansen, M. T., & Ledet, T. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3600363 · Cited by 134
Yamashita, H., Shimada, K., Seki, E., Mokuno, H., & Daida, H. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)03097-7 · Cited by 130
Shi, J., Wang, J., Zheng, H., Ling, W., Joseph, J., Li, D., Mehta, J. L., Ponnappan, U., Lin, P., Fink, L. M., et al. (2003) · Blood Coagulation & Fibrinolysis · doi:10.1097/00001721-200309000-00010 · Cited by 121
Walter, D. H., Fichtlscherer, S., Britten, M. B., Rosin, P., Auch–Schwelk, W., Schächinger, V., & Zeiher, A. M. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01662-x · Cited by 118
Inoue, I., Itoh, F., Aoyagi, S., Tazawa, S., Kusama, H., Akahane, M., Mastunaga, T., Hayashi, K., Awata, T., Komoda, T., et al. (2002) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.6141 · Cited by 116
Wani, M. A., Wert, S. E., & Lingrel, J. B. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.30.21180 · Cited by 114
山下, 晴. (2003) · Medical Entomology and Zoology · Cited by 114
John, S., Delles, C., Jacobi, J., Schlaich, M. P., Schneider, M. P., Schmitz, G., & Schmieder, R. E. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01128-7 · Cited by 110
Effect of fluvastatin on acute renal allograft rejection: A randomized multicenter trial
Holdaas, H., Jardine, A. G., Wheeler, D. C., Brekke, I. B., Conlon, P. J., Fellström, B., Hammad, A., Holme, I., Isoniemi, H., Moore, R. H., et al. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00010.x · Cited by 110
Wagner, A. H., Gebauer, M., Güldenzoph, B., & Hecker, M. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000037098.20829.31 · Cited by 109
Trion, A., de Maat, M. P. M., Jukema, J. W., van der Laarse, A., Maas, M., Offerman, E. H., Havekes, L. M., Szalai, A. J., Princen, H. M. G., & EMEIS, J. J. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000171992.36710.1e · Cited by 109
Yang, Z., Kozai, T., van der Loo, B., Viswambharan, H., Lachat, M. L., Turina, M. I., Maliñski, T., & Lüscher, T. F. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00924-4 · Cited by 104
Järvisalo, M. J., Toikka, J., Vasankari, T. J., Mikkola, J., Viikari, J. S. A., Hartiala, J., & Raitakari, O. T. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(99)00189-6 · Cited by 102
Short-Term Atorvastatin Treatment Improves Endothelial Function in Hypercholesterolemic Women
Marchesi, S., Lupattelli, G., Siepi, D., Schillaci, G., Vaudo, G., Roscini, A. R., Sinzinger, H. F., & Mannarino, E. (2000) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200011000-00011 · Cited by 95
Landrier, J., Thomas, C., Grober, J., Duez, H., Percevault, F., Souidi, M., Linard, C., Staels, B., & Besnard, P. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407461200 · Cited by 93
The Small GTP-Binding Protein Rho Potentiates AP-1 Transcription in T Cells
Chang, J., Pratt, J. C., Sawasdikosol, S., Kapeller, R., & Burakoff, S. J. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.9.4986 · Cited by 89
Wilson, K. M., Fry, G. L., Chappell, D. A., Sigmund, C. D., & Medh, J. D. (2001) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/hq1101.097805 · Cited by 87
Chen, Z., Fukutomi, T., Zago, A. C., Ehlers, R., Detmers, P. A., Wright, S. D., Rogers, C., & Simon, D. I. (2002) · Circulation · doi:10.1161/01.cir.0000022843.76104.01 · Cited by 85
Hernández-Presa, M. Á. (2002) · Cardiovascular Research · doi:10.1016/s0008-6363(02)00619-3 · Cited by 83
An Emerging Role for Krüppel-Like Factors in Vascular Biology
Feinberg, M. W., Lin, Z., Fisch, S., & Jain, M. K. (2004) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2004.06.005 · Cited by 83
Self-citationMontaner, S., Perona, R., Saniger, L., & Lacal, J. C. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.13.8506 · Cited by 83
Integrin-dependent Leukocyte Adhesion Involves Geranylgeranylated Protein(s)
Liu, L., Moesner, P., Kovach, N. L., Bailey, R. D., Hamilton, A. D., Sebti, S. M., & Harlan, J. M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.47.33334 · Cited by 78
HMG-CoA Reductase Inhibitors Inhibit Endothelial Exocytosis and Decrease Myocardial Infarct Size
Yamakuchi, M., Greer, J. J. M., Cameron, S. J., Matsushita, K., Morrell, C. N., Fox-Talbot, K., Baldwin, W. M., Lefer, D. J., & Lowenstein, C. J. (2005) · Circulation Research · doi:10.1161/01.res.0000170229.49776.81 · Cited by 71
Buchwald, H., Campos, C. T., Boen, J. R., Nguyen, P. A., & Williams, S. E. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)80006-3 · Cited by 69
Global Analysis of RNA Expression Profile in Human Vascular Cells Treated with Statins
Morikawa, S., Takabe, W., Mataki, C., Wada, Y., Izumi, A., Saitō, Y., Hamakubo, T., & Kodama, T. (2004) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.11.62 · Cited by 63
Balbay, Y., Tıkız, H., Baptiste, R. J., Ayaz, S., Şaşmaz, H., & Korkmaz, Ş. (2001) · Angiology · doi:10.1177/000331970105200204 · Cited by 60
Marx, N., Libby, P., & Plutzky, J. (2001) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1177/174182670100800404 · Cited by 53
Influence of cholesterol-lowering on plasma membrane lipids and function.
Lijnen, P., Echevaría-Vázquez, D., & Petrov, V. (1996) · PubMed · Cited by 43
Thakur, N. K., Hayashi, T., Sumi, D., Kano, H., Tsunekawa, T., & Iguchi, A. (2001) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2001.281.1.h75 · Cited by 42
Effects of Statins in Thrombosis and Aortic Lesion Development in a Dyslipemic Rabbit Model
Alfon, J. A., Palazón, C. P., Royo, T., & Badimón, L. (1999) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1614576 · Cited by 41
Plutzky, J. (2003) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.08.017 · Cited by 31
Komuro (2001) · doi:10.1002/1529-0131(200112)44:12
Cited by
Cancer-related inflammation and treatment effectiveness
Diakos, C. I., Charles, K. A., McMillan, D. C., & Clarke, S. J. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70263-3 · Cited by 2,193
Adipose tissue dysfunction in obesity, diabetes, and vascular diseases
Hajer, G. R., van Haeften, T. W., & Visseren, F. L. J. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn387 · Cited by 1,410
Macrophage Phenotype and Function in Different Stages of Atherosclerosis
Tabas, I., & Bornfeldt, K. E. (2016) · Circulation Research · doi:10.1161/circresaha.115.306256 · Cited by 1,121
GISSI-HF investigators (2008) · The Lancet · doi:10.1016/s0140-6736(08)61240-4 · Cited by 1,106
Mammalian Krüppel-Like Factors in Health and Diseases
McConnell, B. B., & Yang, V. W. (2010) · Physiological Reviews · doi:10.1152/physrev.00058.2009 · Cited by 1,018
Metadata
- Authors
- Jain, M. K., & Ridker, P. M.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2005-11-24
- Volume
- 4
- Issue
- 12
- Pages
- 977-987
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2017871510
- Cited by
- 915
- References
- 169
- FWCI
- 1.24
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.